Sign in to continue:

Saturday, April 18th, 2026

Category: Hong Kong Corporate News

CanSino Biologics Obtains PIC/S GMP Certificate for MCV4 and PCV13 Vaccines from Malaysia NPRA 1

CanSino Biologics Inc. Obtains PIC/S GMP Certificate: Invest...